Seed Wealth Management Inc. Reduces Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Seed Wealth Management Inc. lowered its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.6% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 2,360 shares of the financial services provider’s stock after selling 140 shares during the quarter. Seed Wealth Management Inc.’s holdings in iShares Biotechnology ETF were worth $323,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Future Financial Wealth Managment LLC purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $27,000. Pacifica Partners Inc. grew its position in iShares Biotechnology ETF by 118.2% in the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 130 shares during the last quarter. Crewe Advisors LLC increased its stake in iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 78 shares during the period. Northwest Financial Advisors bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $42,000. Finally, Values First Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at $43,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.0 %

IBB stock traded down $0.01 during trading on Thursday, hitting $137.91. The company had a trading volume of 971,413 shares, compared to its average volume of 1,647,746. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16. The company has a 50 day simple moving average of $133.90 and a 200-day simple moving average of $134.71.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.